Filing excerpt
On July 30, 2026, Kyndryl Holdings, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) at which the Company’s stockholders approved the Amended and Restated Kyndryl 2021 Long-Term Performance Plan (the “Amended Plan”), which increased the number of shares of the Company’s common stock, par value $0.01 per share, issuable under the Amended Plan by 7,600,000 shares.